These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24904053)

  • 1. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):229-35. PubMed ID: 24904053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.
    Booth TC; Nathan M; Waldman AD; Quigley AM; Schapira AH; Buscombe J
    AJNR Am J Neuroradiol; 2015 Feb; 36(2):236-44. PubMed ID: 24924549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
    Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
    Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders.
    Subramaniam RM; Frey KA; Hunt CH; Mercier GA; Solnes LB; Colletti PM; Lu Y; Savir-Baruch B; Williams HT
    Clin Nucl Med; 2017 Nov; 42(11):847-852. PubMed ID: 28922189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V; Grosset D
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of DAT-SPECT in movement disorders.
    Kägi G; Bhatia KP; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.
    Ba F; Martin WR
    Parkinsonism Relat Disord; 2015 Feb; 21(2):87-94. PubMed ID: 25487733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
    Nicastro N; Nencha U; Burkhard PR; Garibotto V
    J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical Overview of
    Mercer MK; Revels JW; Blacklock LC; Banks KP; Johnson LS; Lewis DH; Kuo PH; Wilson S; Elojeimy S
    Radiographics; 2024 Feb; 44(2):e230133. PubMed ID: 38236751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Imaging of the Dopamine Transporter.
    Palermo G; Ceravolo R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31405186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of imaging in the diagnosis of vascular parkinsonism.
    Zijlmans JC
    Neuroimaging Clin N Am; 2010 Feb; 20(1):69-76. PubMed ID: 19959019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome.
    Warhadpande DS; Huo J; Libling WA; Stuehm C; Najafi B; Sherman S; Lei H; Roveda JM; Kuo PH
    Sensors (Basel); 2022 Jul; 22(13):. PubMed ID: 35808551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications.
    Ikeda K; Ebina J; Kawabe K; Iwasaki Y
    Intern Med; 2019 Jun; 58(12):1665-1672. PubMed ID: 30799370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical parkinsonism].
    Tysnes OB; Vilming ST
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.